Each week, Matthew shares his conversations with cannabis industry leaders. Hear directly from the CEOs of cannabis companies, medical professionals, legislative advocates, policy makers and the people who are shaping the industry. Learn firsthand what they think investors need to know.
How Cannabis Companies Are Faring in the Wake of the Pandemic
Erich Mauff of Jushi Holdings Inc. shares his industry insider insights.
How COVID-19 Has Changed the Medical Cannabis Industry
Dr. Jordan Tishler explains how the medical cannabis industry has changed since the pandemic began.
Why Medical Cannabis Advocates Are Still Battling
Debbie Churgai of Americans for Safe Access talks about the difficulties medical cannabis companies and patients face.
Prospects of Federal Legalization in 2020
Lezli Engelking, founder of FOCUS, talks about what to expect from the cannabis industry in 2020.
“Legislative Roundtable” Part 3: Cannabis M&A and the 2020 Election
Justin and Morgan provide their take on what to expect from cannabis M&A in 2020.
What’s Next for U.S. CBD? Former Cop Weighs In
Andy Snyder, founder of Manward Press, is seeking to educate consumers about the potential benefits that hemp-derived CBD can offer.
Medical Marijuana Opportunity Out of Israel
Israel is a hotbed for medical marijuana companies and research.
Will Marijuana Prohibition End in 2020?
In this episode, we delve into the growing number of legislative efforts to end marijuana prohibition.
From Cannabis Gummies to Gains: A Look Into Plus Products
Plus Products is taking steps to become a national brand and edibles market pioneer.